StromaBio
Pre-clinicalSwedish StromaBio was founded in 2018 with the aim to develop registered products based on mesenchymal stromal cells (MSC).
Founded
2018
Focus
Cell & Gene Therapy
About
Swedish StromaBio was founded in 2018 with the aim to develop registered products based on mesenchymal stromal cells (MSC).
Funding History
1Total raised: $1.2M
Seed$1.2MUppsala University HoldingJun 15, 2021
Company Info
TypePrivate
Founded2018
LocationStockholm, Sweden
StagePre-clinical
Contact
SIMILAR COMPANIES
Basic Genomics
Pre-clinical · Stockholm
2A Pharma
Phase 1 · Stockholm
Abliva
Pre-clinical · Lund
Affibody
Phase 1 · Solna
Alligator Bioscience
Phase 1 · Lund
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile